Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Auxogyn Inc.

This article was originally published in Start Up

Executive Summary

Auxogyn Inc. believes it has found a way to increase the success rate of in vitro fertilization procedures. Its new, noninvasive imaging technology is designed to provide novel data regarding the viability of an embryo, and using time-lapse imaging, will allow embryologists to determine which embryos have the highest likelihood of developing into blastocytes and result in a health pregnancy.
Advertisement

Related Content

The A-List: 2010's Trend-Shaping Series A Financings
Personalized Medicine In 2010: Welcome To The Establishment
The A-List: 2010's Trend-Shaping Series A Financings
Start-Up Previews (12/2010)
Start-Up Previews (12/2010)

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC091907

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel